Total results2,176
Search criteria
All records
Number of publications supporting the inclusion of this protein in EV MemProt Atlas.
Annotation confidence score; open for threshold definitions.
Extremely high >= 0.70High >= 0.60Medium >= 0.40Low >= 0.30| UniProt ID | Protein names | Protein classification | Transmembrane count | Related Diseases | Mediation categories | Download | ||||
|---|---|---|---|---|---|---|---|---|---|---|
| ATP4A | P20648 | Potassium-transporting ATPase alpha chain 1 (EC 7.2.2.19) (Gastric H(+)/K(+) ATPase subunit alpha) (Proton pump) | EnzymesFDA approved drug targetsMetabolic proteins | 10 | Bacterial infectionCardiovascular diseaseColorectal cancer | Clinical-translation mediationFusion and delivery mediation | 0 | 0.35 | ||
| B3AT | P02730 | Band 3 anion transport protein (Anion exchange protein 1) (AE 1) (Anion exchanger 1) (Solute carrier family 4 member 1) (CD antigen CD233) | Blood group antigen proteinsCD markersDisease related genes | 12 | ElliptocytosisHereditary hemolytic anemia | Clinical-translation mediationFusion and delivery mediationImmune mediation | 0 | 0.35 | ||
| BT3A2 | P78410 | Butyrophilin subfamily 3 member A2 | Predicted intracellular proteinsPredicted membrane proteins | 1 | Fusion and delivery mediationImmune mediation | 0 | 0.35 | |||
| COPT1 | O15431 | High affinity copper uptake protein 1 (Copper transporter 1) (hCTR1) (Solute carrier family 31 member 1) [Cleaved into: Truncated CTR1 form] | Metabolic proteinsPredicted membrane proteinsTransporters | 3 | Epilepsy | Clinical-translation mediationFusion and delivery mediation | 0 | 0.35 | ||
| CTL4 | Q53GD3 | Choline transporter-like protein 4 (Solute carrier family 44 member 4) (Thiamine pyrophosphate transporter 1) (hTPPT1) | Disease related genesHuman disease related genesMetabolic proteins | 10 | DeafnessNon-syndromic deafnessPancreatic cancer | Clinical-translation mediationFusion and delivery mediationMetabolism mediation | 0 | 0.35 | ||
| EAA3 | P43005 | Excitatory amino acid transporter 3 (Excitatory amino-acid carrier 1) (Neuronal and epithelial glutamate transporter) (Sodium-dependent glutamate/aspartate transporter 3) (Solute carrier family 1 member 1) | Disease related genesHuman disease related genesMetabolic proteins | 8 | Schizophrenia | Clinical-translation mediationFusion and delivery mediationImmune mediation | 0 | 0.35 | ||
| IPSP | P05154 | Plasma serine protease inhibitor (Acrosomal serine protease inhibitor) (Plasminogen activator inhibitor 3) (PAI-3) (PAI3) (Protein C inhibitor) (PCI) (Serpin A5) | Cancer-related genesCandidate cardiovascular disease genesPlasma proteins | COVID-19 | Clinical-translation mediationFusion and delivery mediationImmune mediation | 0 | 0.35 | |||
| LAT2 | Q9UHI5 | Large neutral amino acids transporter small subunit 2 (L-type amino acid transporter 2) (hLAT2) (Solute carrier family 7 member 8) | Metabolic proteinsPredicted membrane proteinsTransporters | 12 | Fusion and delivery mediationImmune mediation | 0 | 0.35 | |||
| LAT4 | Q8N370 | Large neutral amino acids transporter small subunit 4 (L-type amino acid transporter 4) (Solute carrier family 43 member 2) | Metabolic proteinsPredicted membrane proteinsTransporters | 12 | Fusion and delivery mediation | 0 | 0.35 | |||
| MGA | O43451 | Maltase-glucoamylase (Alpha-1,4-glucosidase) (EC 3.2.1.20) | EnzymesFDA approved drug targetsMetabolic proteins | 1 | Acute diabetic complicationBlood chemistry clinical symptomCardiovascular disease | Clinical-translation mediationFusion and delivery mediationImmune mediation | 0 | 0.35 |